Orient Europharma (Taiwan) Buy Hold or Sell Recommendation
| 4120 Stock | TWD 41.25 0.40 0.96% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Orient Europharma Co is 'Strong Sell'. Macroaxis provides Orient Europharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 4120 positions. The advice algorithm takes into account all of Orient Europharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Orient Europharma's buy or sell advice are summarized below:
Real Value 34.37 | Hype Value 41.05 | Market Value 41.25 | Naive Value 38.68 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Orient Europharma Co given historical horizon and risk tolerance towards Orient Europharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Orient Europharma Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Orient |
Execute Orient Europharma Buy or Sell Advice
The Orient recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Orient Europharma Co. Macroaxis does not own or have any residual interests in Orient Europharma Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Orient Europharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Orient Europharma Trading Alerts and Improvement Suggestions
| Orient Europharma has high likelihood to experience some financial distress in the next 2 years | |
| About 65.0% of the company shares are owned by insiders or employees |
Orient Europharma Returns Distribution Density
The distribution of Orient Europharma's historical returns is an attempt to chart the uncertainty of Orient Europharma's future price movements. The chart of the probability distribution of Orient Europharma daily returns describes the distribution of returns around its average expected value. We use Orient Europharma Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Orient Europharma returns is essential to provide solid investment advice for Orient Europharma.
| Mean Return | 0.14 | Value At Risk | -2.48 | Potential Upside | 2.82 | Standard Deviation | 1.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Orient Europharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Orient Europharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orient Europharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orient Europharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orient stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.13 | |
β | Beta against NYSE Composite | -0.1 | |
σ | Overall volatility | 1.22 | |
Ir | Information ratio | 0.03 |
Orient Europharma Volatility Alert
Orient Europharma Co has relatively low volatility with skewness of 0.48 and kurtosis of 1.54. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Orient Europharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Orient Europharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Orient Europharma Fundamentals Vs Peers
Comparing Orient Europharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Orient Europharma's direct or indirect competition across all of the common fundamentals between Orient Europharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Orient Europharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Orient Europharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Orient Europharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Orient Europharma to competition |
| Fundamentals | Orient Europharma | Peer Average |
| Return On Equity | -0.0268 | -0.31 |
| Return On Asset | -0.0027 | -0.14 |
| Profit Margin | (0.02) % | (1.27) % |
| Operating Margin | (0.01) % | (5.51) % |
| Current Valuation | 5.9 B | 16.62 B |
| Shares Outstanding | 86.75 M | 571.82 M |
| Shares Owned By Insiders | 65.10 % | 10.09 % |
| Shares Owned By Institutions | 0.45 % | 39.21 % |
| Price To Book | 1.07 X | 9.51 X |
| Price To Sales | 0.68 X | 11.42 X |
| Revenue | 4.77 B | 9.43 B |
| Gross Profit | 2.15 B | 27.38 B |
| EBITDA | 313.89 M | 3.9 B |
| Net Income | 120.17 M | 570.98 M |
| Total Debt | 1.68 B | 5.32 B |
| Book Value Per Share | 33.54 X | 1.93 K |
| Cash Flow From Operations | 77.65 M | 971.22 M |
| Earnings Per Share | 0.54 X | 3.12 X |
| Number Of Employees | 21 | 18.84 K |
| Beta | 0.4 | -0.15 |
| Market Capitalization | 3.13 B | 19.03 B |
| Total Asset | 9.4 B | 29.47 B |
| Z Score | 0.6 | 8.72 |
| Annual Yield | 0.02 % | |
| Net Asset | 9.4 B | |
| Last Dividend Paid | 0.85 |
Orient Europharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Orient . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Orient Europharma Buy or Sell Advice
When is the right time to buy or sell Orient Europharma Co? Buying financial instruments such as Orient Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Orient Europharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Personal Services Thematic Idea Now
Personal Services
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Personal Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Personal Services Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Orient Europharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Orient Stock analysis
When running Orient Europharma's price analysis, check to measure Orient Europharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Europharma is operating at the current time. Most of Orient Europharma's value examination focuses on studying past and present price action to predict the probability of Orient Europharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Europharma's price. Additionally, you may evaluate how the addition of Orient Europharma to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |